Evaluation of aprepitant and fosaprepitant in pediatric patients

Saito, Y; Kumamoto, T; Arima, T; Shirakawa, N; Ishimaru, S; Sonoda, T; Nakajima, M; Sugiyama, M; Arakawa, A; Hashimoto, H; Makino, Y; Ogawa, C; Yamaguchi, M

Saito, Y (reprint author), Natl Canc Ctr, Dept Pharm, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.

PEDIATRICS INTERNATIONAL, 2019; 61 (3): 235

Abstract

Background Single-dose i.v. fosaprepitant has been approved as an alternative to 3 day oral aprepitant, a neurokinin-1 receptor antagonist, and improv......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索